On April 5, 2013, U.S. District Court Judge Edward Korman ordered the Food and Drug Administration (FDA) to lift the age restriction on emergency contraception, known commonly as “the morning after pill” or “Plan B.” The FDA has since approved Plan B One-Step, a brand of emergency contraception, to be made available over-the-counter for women aged 15 and older.
Plan B is intended to be used when other contraception methods fail, such as when a condom breaks. The pill contains the synthetic hormone levonorgestrel, and works by preventing a fertilized egg from attaching itself to the uterine wall. It must be taken within 72 hours of unprotected intercourse. Plan B prevents pregnancy from occurring. Contrary to the arguments put forth by anti-choice lobbyists, it cannot terminate an existing pregnancy.
“This is a thinly-veiled attempt to get an abortion drug over-the-counter,” said Dr. Donna Harrison, president of the American Association of Pro-Life Obstetricians and Gynecologists.
Central to the contentious debate over the ethics of the drug’s use is the disagreement over the exact moment that pregnancy begins. Pro-life arguments contend that pregnancy begins with fertilization, which typically occurs within 24 hours after intercourse, if a woman has just ovulated. However, many obstetricians and gynecologists maintain that, as it takes 5-7 days for the fertilized egg to implant in the uterus and begin to grow, if one interrupts the process before this implantation takes place, pregnancy never begins.
Despite the controversy associated with emergency contraception, the good news is women seeking to purchase Plan B will now be able to find it in the family planning and female health aisles of commercial retail stores, instead of having to rely on regular pharmacy opening hours. Cecile Richards, President of Planned Parenthood Federation of America, welcomed the decision, stating:
“While there are still practical questions to resolve, this is an important step forward to expand access to emergency contraception and for preventing unintended pregnancy.”




Planned Parenthood vs. Komen
“Cry me a freaking river.”
Those are the words Karen Handel, Vice President of the Susan G. Komen Foundation, relayed to pro-choice advocacy groups—before she deleted them, that is. Handel retweeted the sentiment, which criticized pro-choice groups for responding negatively to Komen’s decision to pull funding for Planned Parenthood.
The Komen Foundation announced Jan. 31 that it would no longer fund Planned Parenthood’s breast cancer screenings made available to low-income women. The reasoning provided to the public was that a recent change in policy would not allow The Komen Foundation to support an organization under criminal investigation.
Yeah.
The excuse was taken for what it was: A thinly-veiled political move—largely engineered by VP Handel—against the pro-choice powerhouse. In an article on the Huffington Post web site, an anonymous source in the Komen Foundation points the finger at Handel as “the prime instigator of this effort.”
The source told the Huffington Post:
And before you jump to declare “Hearsay!,” the article later confirmed Handel as the driving force in the drafting of the foundation’s new policy, based on e-mails between Komen officials on the day of the announcement.
Following the decision, the foundation was beaten with a fervent backlash by angry citizens, celebrities, and even members of Congress. Twenty-six senators signed a letter to Komen founder Nancy Brinkler urging her to reconsider the decision, saying:
Leave a Comment
Filed under Commentary, Opinion
Tagged as Abortion, breast cancer, Planned Parenthood, Pro-choice, Pro-life, Susan G. Komen